Initial preclinical and clinical studies have demonstrated ARA-290s broad therapeutic potential, particularly in conditions characterized by inflammation, tissue damage, and neuropathy
Subcutaneous injection (compounded prescription) Published clinical protocols report typical dose ranges of 1 to 3 mg subcutaneously, administered daily or several times per week, adjusted for the individual patient by their prescribing provider
However, it should be possible if needed by measurement of gamma-glutamylcysteine synthetase activity or mutational analysis (if the mutation in the family is known) of chorionic villi or cultured amniocytes
Skudlarski P, Schretlen DJ, Thaker GK, Stevens MC, Keshavan MS, Sweeney JA et al
The relationship between TIMP-2 and GSH in the ACC seemed marginally group dependent ( = 0.784, p =0.051, see Figure 4), where the relationship was positive in PTSD participants but negative among HC participants